Grünenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between Grünenthal and Kyowa Kirin.

Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. Through a network of affiliates and key partners, we are bringing these important products to patients in need around the globe.

Health Care

Life Sciences

Pharmaceutical

Therapeutics

Grünenthal Meds

Grünenthal Meds' headquarters in Galashiels, United Kingdom

Description

People (6)

Jobs (0)

Other offices